Efficacy and safety of canagliflozin in type 2 diabetes mellitus patients with biopsy-proven nonalcoholic steatohepatitis classified as stage 1-3 fibrosis.
Diabetes Metab Syndr Obes
; 11: 835-843, 2018.
Article
in En
| MEDLINE
| ID: mdl-30568471
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Type of study:
Observational_studies
/
Risk_factors_studies
Language:
En
Journal:
Diabetes Metab Syndr Obes
Year:
2018
Document type:
Article
Country of publication:
Nueva Zelanda